Biogen (BIIB) receives European Commission approval for high dose regimen of Spinraza (Nusinersen) for spinal muscular atrophy
Biogen's approval of the high dose regimen of Spinraza by the European Commission could signal enhanced treatment options for spinal muscular atrophy, positively impacting the drug's revenue potential.
Novo Nordisk (NVO) CEO says Trump administration's straightforward approach has made deal-making easier, via JP Morgan conference
Apple (AAPL) and Google (GOOGL) confirm they have entered into a multi-year deal where next generation of Apple Foundation models will be based on Google's Gemini models
Biogen (BIIB) receives European Commission approval for high dose regimen of Spinraza (Nusinersen) for spinal muscular atrophy
Republican Senator Murkowski says if DoJ believes an investigation into Fed Chair Powell is warranted based on project cost overruns then congress needs to investigate the DoJ
Newsquawk Daily Economic Releases - 13th January 2026
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This development might strengthen Biogen's position in the biotechnology sector and could elicit bullish sentiment in both the stock and related biotech equities. Watch for potential peer movement as investors assess the implications for competition in the market.
Related headlines
- Daily US Equity Opening News: ORCL gains on earnings and FY guidance beat; ADBE weighed by slight Q4 revenue miss; SMR downgraded2 days ago
- US EQUITY OPEN: US indices reverse initial CPI losses2 days ago
- Burry adds to his positions in Zoetis (ZTS) and Lululemon (LULU); sold entire position in Flutter (FLUT)1 day ago
- Estee Lauder (EL) reportedly advances against Walmart (WMT) over knockoffs, according to Bloomberg Law2 days ago
- Google (GOOGL) just completed its USD 1.5bln-plus deal for AI startup Mechanize, reports Business Insider1 day ago
- Paypal's (PYPL) new chief executive, Enrique Lores, is mapping out his plans for going it alone rather than selling the company for more than USD 50bln, reports WSJ2 days ago
- Fox's Gasparino says "Paramount’s (PSKY) CEO has "tricks up his sleeve" to get his Warner (WBD) acquisition cleared in California"2 days ago
- US PREMARKET MOVERS: ORCL, ADBE, ACVA, KR, RH, CELH, GME, NVO, SMR2 days ago
- US BROKER MOVES: IP upgraded at BofA; NVO downgraded at Morgan Stanley2 days ago
- EU officials have questioned cloud providers for more information ahead of a key deadline in their argument with Broadcom (AVGO) over the licensing overhaul for VMware, Bloomberg reports2 days ago
- TikTok has reportedly rejected advertisements from Meta (META) that call on the Co. and other tech platforms to join Meta in settling with US state AGs in a children's safety lawsuit, Axios reports2 days ago
- Newsquawk US Market Wrap: Markets chop, and yields flatten after hot core CPI boosts Fed rate hike bets1 day ago
- US President Trump reiterates USD 5k payment to all US adults will happen 1 day ago
- CRUDE WRAP: WTI (V6) SETTLES USD 2.43 LOWER AT 100.05/BBL; BRENT (X6) SETTLES USD 3.02 LOWER AT 104.61/BBL1 day ago
- Saudi Crown Prince MBS has personally urged President Trump to launch military strikes against Houthi forces in Yemen amid their rapid advance along the Red Sea coast, reports to CBS citing sources2 days ago
- US President Trump reiterates that Iran will never possess a nuclear weapon2 days ago
- FanDuel (FLTR) and other sports betting operators are market making on Kalshi, reports Barrons2 days ago
- Newsquawk Weekly US Earnings Estimates: 14-18th September 2026: LEN the only earning all week1 day ago
- Corning (GLW) files for a USD 2bln common stock offering of up to USD 2.0bln1 day ago
- Chevron (CVX) CEO says early buffers in the oil market have played out and that the price risk from the Iran war is now higher2 days ago
The whole workspace, free to try.
Try it free